Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CHEMBIO DIAGNOSTICS, INC. (CEMI)
|
Add to portfolio |
|
|
|
| Price: |
$3.89
| | Metrics |
| OS: |
30.2
|
M
| |
-199
|
% ROE
|
| Market cap: |
$118
|
M
| |
-2480
|
% ROIC
|
|
Net cash:
|
$18.1
|
M
| |
$0.60
|
per share
|
|
EV:
|
$99.4
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($18.3)
|
M
| |
|
|
|
EBIT
|
($22.5)
|
M
| |
|
|
| EPS |
($1.34)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 47.8 | 32.5 | 34.5 | 34.6 | 24.0 | 17.9 | 24.3 | 27.6 |
| Revenue growth | 47.3% | -5.8% | -0.3% | 44.0% | 34.4% | -26.3% | -12.3% | -6.4% |
| Cost of goods sold | 34.5 | 23.9 | 22.4 | 22.6 | 12.9 | 9.4 | 13.8 | 16.8 |
| Gross profit | 13.3 | 8.6 | 12.1 | 12.0 | 11.1 | 8.5 | 10.5 | 10.8 |
| Gross margin | 27.9% | 26.5% | 35.0% | 34.6% | 46.2% | 47.3% | 43.2% | 39.1% |
| Selling, general and administrative | 24.8 | 21.0 | 16.1 | 11.1 | 9.0 | 7.6 | 7.7 | 7.5 |
| Research and development | 12.5 | 9.5 | 8.5 | 8.5 | 8.6 | 8.4 | 6.4 | 4.8 |
| EBITA | -20.9 | -21.4 | -12.1 | -7.6 | -6.3 | -7.6 | -3.6 | -1.6 |
| EBITA margin | -43.8% | -65.8% | -35.1% | -22.1% | -26.1% | -42.4% | -14.7% | -5.6% |
| Amortization of intangibles | 0.5 | 0.6 | 0.5 | | | | | |
| EBIT | -21.4 | -22.0 | -12.6 | -7.6 | -6.3 | -7.6 | -3.6 | -1.6 |
| EBIT margin | -44.8% | -67.6% | -36.6% | -22.1% | -26.1% | -42.4% | -14.7% | -5.6% |
| Pre-tax income | -34.0 | -26.0 | -14.2 | -7.9 | -6.5 | -7.5 | -3.6 | -1.6 |
| Income taxes | -0.1 | -0.5 | -0.5 | -0.1 | -0.1 | 5.8 | -1.2 | -0.4 |
| Tax rate | 0.2% | 1.8% | 3.5% | 0.9% | 1.4% | | 32.6% | 26.6% |
| Net income | -33.9 | -25.5 | -13.7 | -7.9 | -6.4 | -13.3 | -2.4 | -1.1 |
| Net margin | -70.9% | -78.6% | -39.7% | -22.7% | -26.5% | -74.7% | -9.9% | -4.1% |
| |
| Diluted EPS | ($1.40) | ($1.34) | ($0.81) | ($0.54) | ($0.52) | ($1.26) | ($0.25) | ($0.12) |
| Shares outstanding (diluted) | 24.3 | 19.1 | 17.0 | 14.4 | 12.3 | 10.6 | 9.6 | 9.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|